Brief: Ascendis Pharma A/S Reports Q2 Loss Per Share Eur 1.25
Aug 28 (Reuters) - Ascendis Pharma A/S ASND.O :
* REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS
* Q2 LOSS PER SHARE EUR 1.25
* Q2 REVENUE EUR 3.2 MILLION
* Q2 REVENUE ESTIMATE EUR 253,000 -- REFINITIV IBES DATA
* Q2 EARNINGS PER SHARE ESTIMATE EUR -1.21 -- REFINITIV IBES
DATA
* AS OF JUNE 30, 2019, ASCENDIS HAD CASH AND CASH
EQUIVALENTS OF
EUR 690.4 MILLION COMPARED TO EUR 696.7 MILLION AS OF MARCH 31,
2019
Source text for Eikon: ID:nGNX52ZkS3
Further company coverage: ASND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascendis Pharma A/S
See all newsAscendis Pharma tumbles on Novo Nordisk collab termination
BioMarin climbs on global patent settlement with Ascendis
Brief: Ascendis Announces Oral Presentation Of Week 104 Data From Its Pivotal Trial Of Transcon® CNP (Navepegritide) At Isds 2026
Brief: Eyconis Announces Initiation Of First-In-Human Clinical Trial Of Eyc-0305 In Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Ascendis Pharma A/S reports results for the quarter ended June 30 - Earnings Summary